French of the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer

Powles, Thomas; Hoon Park, Se; Voog, Eric; Caserta, Claudia; Valderrama, Begoña P.; Gurney, Howard; Kalofonos, Haralabos; Radulovic, Sinisa; Demey, Wim; Ullén, Anders; Loriot, Yohann; Sridhar, Srikala S.; Tsuchiya, Norihiko; Kopyltsov, Evgeny; Sternberg, Cora N.; Bellmunt, Joaquim; Aragon-Ching, Jeanny B.; Petrylak, Daniel P.; Laliberte, Robert J.; Huang, Bo; Costa, Nuno; Blake-Haskins, John A.; Grivas, Petros

doi:10.25402/FON.22006748.v1

french_final.pdf (3.92 MB)

French of the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer

journal contribution

posted on 2023-02-03, 16:20 authored by Thomas Powles, Se Hoon Park, Eric Voog, Claudia Caserta, Begoña P. Valderrama, Howard Gurney, Haralabos Kalofonos, Sinisa Radulovic, Wim Demey, Anders Ullén, Yohann Loriot, Srikala S. Sridhar, Norihiko Tsuchiya, Evgeny Kopyltsov, Cora N. Sternberg, Joaquim Bellmunt, Jeanny B. Aragon-Ching, Daniel P. Petrylak, Robert J. Laliberte, Bo Huang, Nuno Costa, John A. Blake-Haskins, Petros Grivas

French Translation

History

Usage metrics

Keywords

Plain Language Summary immunotherapy maintenance treatment bladder cancer Urothelial Cancer JAVELIN Bladder 100 avelumab lay summary

Licence

CC BY-NC-ND 4.0

French of the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer

History

Usage metrics

Categories

Keywords

Licence

Exports